Skånes Universitetssjukhus Malmö
- Address
- Jan Waldenströms gata 15, 20502 Malmö, Sweden
Skånes Universitetssjukhus Malmö
Skånes Universitetssjukhus Malmö is a leading academic medical center engaged in advanced clinical research across multiple therapeutic areas. The center demonstrates particular expertise in conducting large-scale international trials focused on cardiovascular disease prevention and urological oncology.
- Advanced prostate cancer research, including hormonal therapies and combination treatment strategies
- Cardiovascular disease prevention and lipid management in patients with established atherosclerotic disease
- Novel therapeutic interventions for reducing cardiovascular events and mortality
The center's research portfolio includes pivotal studies evaluating enzalutamide combinations in high-risk nonmetastatic prostate cancer and innovative approaches to LDL cholesterol reduction using inclisiran to prevent major adverse cardiovascular events. With expertise in both oncological and cardiovascular clinical trials, the center contributes significantly to evidence-based medicine and the development of new treatment paradigms for patients with life-threatening conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 19 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Karolinska Institutet1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Skånes Universitetssjukhus Malmö
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Proof-of-Concept Study of Rituximab for the Treatment of Autoantibody-Mediated Fibromyalgia | Region Stockholm – SLSO | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 19 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abatacept | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.